ArticleJournal of medical ultrasound
Successful Ultrasound Guided Sclerotherapy Technique for the Management of a Microcystic Warthin's Tumor.
Article in Journal of medical ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrasonographic descriptions of Warthin's tumor (WT) vary from a predominately macrocystic appearance (anechoic with internal septations) to microcystic (multiple, diffuse, 1-2 mm anechoic areas). While the current first-line treatment for WTs is surgical excision, ultrasound-guided ethanol sclerotherapy (UGES) demonstrates success in macrocystic WTs, with aspiration of the cystic contents followed by injection of the sclerosing agent. Typically, microcystic tumors are thought to be unresponsive to sclerotherapy. In this case, we report the first application of ethanol sclerotherapy without ultrasound-guided aspiration for the treatment of a microcystic WT. The patient presented with a 2.0 cm × 1.97 cm × 3.05 cm right parotid mass of 9 years' duration. UGES was performed in clinic under local anesthesia through injection of 97% ethanol in the three separate components of the target lesion. Six months postprocedure, ultrasound evaluation demonstrated a volume reduction rate of 78.53%. The patient reported significant cosmetic improvement and no observed complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.